RBOT

SEC source: 0001213900-23-075087 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 550,050

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.9481 to $0.9915 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-075089 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,783,514

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.9475 to $1.005 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-075085 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 581,276

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.95 to $1.005 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-075088 · ownership.xml · nonDerivative · entry 1

Mazzola John · CIK 0001430464 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 312,447

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · balance_after: This figure is the weighted average sales price of multiple trades ranging from $0.9481 to $1.005 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-075090 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,253,871

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.9481 to $1.005 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-070746 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 587,661

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.9297 to $0.9684 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-069797 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,797,268

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.887 to $0.9346 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-069799 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 590,161

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.8916 to $0.949 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-069801 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,260,965

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.887 to $0.95 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-069798 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 556,511

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.8881 to $0.9508 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0000899243-23-017901 · doc4.xml · nonDerivative · entry 1

Khosla Ventures V, L.P. · CIK 0001611146 · 10% owner

Khosla Ventures Opportunity II, L.P. · CIK 0001959115 · 10% owner

Khosla Ventures Opportunity Associates II, LLC · CIK 0001959102 · 10% owner

Khosla Ventures Associates V, LLC · CIK 0001611145 · 10% owner

Khosla Ventures Seed C, L.P. · CIK 0001627897 · 10% owner

Khosla Ventures Seed Associates C, LLC · CIK 0001627898 · 10% owner

VK Services, LLC · CIK 0001501927 · 10% owner

KHOSLA VINOD · CIK 0001032453 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 8,000,000

F1 · ownership.nature: Consists of securities held of record by Khosla Ventures Opportunity II, L.P. ("KV Opportunity II"), of which Khosla Ventures Opportunity Associates II, LLC ("KV Opportunity Associates") is the general partner. Vinod Khosla is the managing member of VK Services, LLC ("VK Services") which is the sole manager of KV Opportunity Associates. Each of KV Opportunity Associates V, VK Services, and Vinod Khosla may be deemed to have indirect beneficial ownership of such securities held by KV Opportunity II. Each Reporting Person disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interests therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

SEC source: 0001213900-23-064919 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 562,989

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.8332 to $0.9548 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-055122 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 567,974

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.78 to $1.875 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001013762-23-001025 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,758

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $13,562.50 of cash retainer fees earned during the second quarter of 2023. The RSUs were fully vested on the grant date.

SEC source: 0001213900-23-052069 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 596,568

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.89 to $1.975 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-051008 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 572,833

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.03 to $2.06 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-051006 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,821,519

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.03 to $2.06 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-051009 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 598,692

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.03 to $2.09 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-051011 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,280,366

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.03 to $2.06 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-046722 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 573,939

F2 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $2.12 to $2.225 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-046252 · ownership.xml · nonDerivative · entry 2

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,261,168

F2 · kind: Distribution received from a fund in which the Reporting Person is an investor.

SEC source: 0001213900-23-046257 · ownership.xml · nonDerivative · entry 2

Styka David Michael · CIK 0001884339 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,616

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046722 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 578,808

F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046726 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,825,661

F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046725 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 599,786

F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046730 · ownership.xml · nonDerivative · entry 1

Mazzola John · CIK 0001430464 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,230

F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046723 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,283,679

F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046251 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,348

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046252 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,161,168

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046250 · ownership.xml · nonDerivative · entry 1

HUSS BEVERLY A · CIK 0001222352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,956

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046249 · ownership.xml · nonDerivative · entry 1

Fulop Ric · CIK 0001472305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,629

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046257 · ownership.xml · nonDerivative · entry 1

Styka David Michael · CIK 0001884339 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,629

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046256 · ownership.xml · nonDerivative · entry 1

CARR BRENDEL VICTORIA · CIK 0001962858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,820

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-043216 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,307

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.28 to $2.34 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-042680 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,759

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.090 to $2.34 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-042679 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,178,395

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.090 to $2.350 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-042682 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 301,807

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.095 to $2.335 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-042681 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 949,827

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.090 to $2.335 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-038919 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 730,332

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $1.9584 to $2.0450 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-037359 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,238

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.11 to $2.24 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-029225 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 723,332

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $2.249 to $2.277 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-028787 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 5,925

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-028545 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 700,405

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-028189 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 286,277

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

SEC source: 0001213900-23-027150 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,374

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $12,561.80 of cash retainer fees earned during the first quarter of 2023. The RSUs were fully vested on the grant date.

SEC source: 0001213900-23-024675 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 697,405

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-024084 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 623,105

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-023726 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 549,205

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-022514 · ownership.xml · nonDerivative · entry 2

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308,215

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $1.84 to $1.45 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-023222 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 489,080

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $1.770 to $1.560 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.